Komori
Other Disclosures2934J Frontier Co.,Ltd.Food

TOCASSE, the buzzworthy supplement that sold out of 1,000 units within seven hours on its launch day, is now available for general sale, offering a new gluten-care routine powered by a Korean-patented gluten-degrading lactic acid bacterium

Group company 株式会社ウェルヴィーナス has begun general sales through its official website and e-commerce marketplaces of the supplement “TOCASSE (Tokase),” which was previously sold exclusively to influencers.

Worth reading
62In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
1000
Units (number sold per day during the presale)
Wording
Conditional
How definitive the wording is.

Announced details

TOCASSE (Tokase)
Applicable field (uses covered by this announcement)

Gluten care and dietary support

Launch date10 April 2026 (general sales launch; actual)
What the company reported numerically
Quantitative Effects

An average maximum gluten breakdown rate of approximately 70% was confirmed in fermentation tests (according to the raw-material manufacturer)

Usage history

1,000 units sold per day in the influencer presale held on 21 January 2026

Relationship between the counterparty and the company
J Frontier Co.,Ltd.2934
Relationship with the Company

株式会社ウェルヴィーナス is a group company of J Frontier Co.,Ltd.

Award/certification name

Korean patent (Dglu-MB0601 strain)

Registration number and expiry date

Patent publication number: 10-2019-0142263; validity period: Not disclosed

Offering price

2-bag set: ¥5,760 (tax included)

The company does not address Contract Value / Impact on Business Performance.

Source (materials cited by the company)

According to the raw-material manufacturer

Announced details
ItemDetails
Names of Products / Services CoveredTOCASSE (Tokase)
Relationship with the Company株式会社ウェルヴィーナス is a group company of J Frontier Co.,Ltd.
Offering price2-bag set: ¥5,760 (tax included)
Launch date10 April 2026 (general sales launch; actual)
Applicable areaGluten care and dietary support
Award/certification nameKorean patent (Dglu-MB0601 strain)
Registration number and expiry datePatent publication number: 10-2019-0142263; validity period: Not disclosed
Quantitative EffectsAn average maximum gluten breakdown rate of approximately 70% was confirmed in fermentation tests (according to the raw-material manufacturer)
Usage history1,000 units sold per day in the influencer presale held on 21 January 2026
SourceAccording to the raw-material manufacturer
Items this document does not state (8)
CounterpartyCounterparty overviewContract ValueContract DateAwarding / certifying bodyLocationLocation scaleImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Sales during the presale exceeded expectations, and the company sought to respond to requests from customers eager for general sales to begin, including comments such as “I want to be able to purchase it more easily.”

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
TOCASSE, the buzzworthy supplement that sold out of 1,000 units within seven hours on its launch day, is now available for general sale, offering a new gluten-care routine powered by a Korean-patented gluten-degrading lactic acid bacterium | J Frontier Co.,Ltd. (2934) timely disclosure | Komori